Cargando…

Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector

In recent years, the Orf virus has become a promising tool for protective recombinant vaccines and oncolytic therapy. However, suitable methods for an Orf virus production, including up- and downstream, are very limited. The presented study focuses on downstream processing, describing the evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lothert, Keven, Pagallies, Felix, Feger, Thomas, Amann, Ralf, Wolff, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403136/
https://www.ncbi.nlm.nih.gov/pubmed/32763261
http://dx.doi.org/10.1016/j.jbiotec.2020.07.023
_version_ 1783566889651273728
author Lothert, Keven
Pagallies, Felix
Feger, Thomas
Amann, Ralf
Wolff, Michael W.
author_facet Lothert, Keven
Pagallies, Felix
Feger, Thomas
Amann, Ralf
Wolff, Michael W.
author_sort Lothert, Keven
collection PubMed
description In recent years, the Orf virus has become a promising tool for protective recombinant vaccines and oncolytic therapy. However, suitable methods for an Orf virus production, including up- and downstream, are very limited. The presented study focuses on downstream processing, describing the evaluation of different chromatographic unit operations. In this context, ion exchange-, pseudo-affinity- and steric exclusion chromatography were employed for the purification of the cell culture-derived Orf virus, aiming at a maximum in virus recovery and contaminant depletion. The most promising chromatographic methods for capturing the virus particles were the steric exclusion- or salt-tolerant anion exchange membrane chromatography, recovering 84 % and 86 % of the infectious virus. Combining the steric exclusion chromatography with a subsequent Capto™ Core 700 resin or hydrophobic interaction membrane chromatography as a secondary chromatographic step, overall virus recoveries of up to 76 % were achieved. Furthermore, a complete cellular protein removal and a host cell DNA depletion of up to 82 % was possible for the steric exclusion membranes and the Capto™ Core 700 combination. The study reveals a range of possible unit operations suited for the chromatographic purification of the cell culture-derived Orf virus, depending on the intended application, i.e. a human or veterinary use, and the required purity.
format Online
Article
Text
id pubmed-7403136
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74031362020-08-05 Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector Lothert, Keven Pagallies, Felix Feger, Thomas Amann, Ralf Wolff, Michael W. J Biotechnol Article In recent years, the Orf virus has become a promising tool for protective recombinant vaccines and oncolytic therapy. However, suitable methods for an Orf virus production, including up- and downstream, are very limited. The presented study focuses on downstream processing, describing the evaluation of different chromatographic unit operations. In this context, ion exchange-, pseudo-affinity- and steric exclusion chromatography were employed for the purification of the cell culture-derived Orf virus, aiming at a maximum in virus recovery and contaminant depletion. The most promising chromatographic methods for capturing the virus particles were the steric exclusion- or salt-tolerant anion exchange membrane chromatography, recovering 84 % and 86 % of the infectious virus. Combining the steric exclusion chromatography with a subsequent Capto™ Core 700 resin or hydrophobic interaction membrane chromatography as a secondary chromatographic step, overall virus recoveries of up to 76 % were achieved. Furthermore, a complete cellular protein removal and a host cell DNA depletion of up to 82 % was possible for the steric exclusion membranes and the Capto™ Core 700 combination. The study reveals a range of possible unit operations suited for the chromatographic purification of the cell culture-derived Orf virus, depending on the intended application, i.e. a human or veterinary use, and the required purity. Elsevier B.V. 2020-11-10 2020-08-05 /pmc/articles/PMC7403136/ /pubmed/32763261 http://dx.doi.org/10.1016/j.jbiotec.2020.07.023 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lothert, Keven
Pagallies, Felix
Feger, Thomas
Amann, Ralf
Wolff, Michael W.
Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector
title Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector
title_full Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector
title_fullStr Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector
title_full_unstemmed Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector
title_short Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector
title_sort selection of chromatographic methods for the purification of cell culture-derived orf virus for its application as a vaccine or viral vector
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403136/
https://www.ncbi.nlm.nih.gov/pubmed/32763261
http://dx.doi.org/10.1016/j.jbiotec.2020.07.023
work_keys_str_mv AT lothertkeven selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector
AT pagalliesfelix selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector
AT fegerthomas selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector
AT amannralf selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector
AT wolffmichaelw selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector